Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
ACCESSWIRE
03 Jun 2023, 06:43 GMT+10
BOSTON, MA / ACCESSWIRE / June 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory and cancer diseases, today announced that Stephen Yoder, president and chief executive officer of Pieris, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 10:00 a.m. ET in New York City.
To access the live webcast of Pieris's fireside chat, please use this link. A replay of the webcast will be available on the Pieris website for 90 days following the event.
About Pieris Pharmaceuticals:
Pieris is a clinical-stage biotechnology company that combines leading protein engineering capabilities and deep understanding into molecular drivers of disease to develop inhaled medicines that drive local biology to produce superior clinical outcomes for patients. Our pipeline is focused on inhalable Anticalin proteins to treat respiratory diseases and locally-activated bispecifics for immuno-oncology. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by strong partnerships with leading pharmaceutical companies. For more information, visit www.pieris.com.
Investor Relations Contact:
Pieris Pharmaceuticals, Inc.
Investors@pieris.com
Joe Patneaude
Kendall Investor Relations
Joe@kendalIir.com
SOURCE: Pieris Pharmaceuticals, Inc.
View source version on accesswire.com:
https://www.accesswire.com/759016/Pieris-Pharmaceuticals-to-Present-at-Jefferies-2023-Healthcare-Conference
Subscribe and Follow
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
News RELEASES
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More Information
70
℉
eVTOL maker Joby chooses Ohio for its flying taxis plant
DAYTON, Ohio: Under an agreement announced this week, Joby Aviation will produce state-of-the-art electric vertical takeoff and landing (eVTOL) aircraft ...
Stocks in U.S. and around world decline as bond yields jump
NEW YORK, New York - U.S. stocks and bonds caught on to a global trend Thursday as sellers took charge ...
Chicago Symphony Orchestra, musicians' union ink a new deal
CHICAGO, Illinois: The Chicago Symphony Orchestra (CSO) and the Chicago Federation of Musicians announced over the weekend that they agreed ...
Alibaba head, President Erdogan debate $2 billion funding in Turkey
ANKARA, Turkey: During a meeting, Michael Evans, President of the Alibaba Group, told Turkish President Tayyip Erdogan that the Chinese ...
Tesla, Saudi Arabia discussing potential EV factory, says WSJ
NEW YORK: This week, the Wall Street Journal (WSJ) reported that U.S. electric vehicle (EV) maker Tesla and Saudi Arabia ...
Nasdaq Composite tumbles 209 points after Fed leaves rates unchanged
NEW YORK, New York - Interest rates could stay higher for longer, but there is the possibility of rate cuts ...
eVTOL maker Joby chooses Ohio for its flying taxis plant
DAYTON, Ohio: Under an agreement announced this week, Joby Aviation will produce state-of-the-art electric vertical takeoff and landing (eVTOL) aircraft ...
Farmers cannot transport crops due to low Mississippi River level
NEW ORLEANS, Louisiana: As Midwest farmers prepare to harvest crops and send tons of grain downriver to the Gulf of ...
US NIH starts early-stage trials of flu vaccines on humans
BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, ...
With season on line, Guardians turn to Shane Bieber vs. O's
(Photo credit: David Richard-USA TODAY Sports) The Cleveland Guardians will turn to a familiar face in a bid to stave ...
Phillies' Nick Castellanos looks to continue success vs. Mets
(Photo credit: Bill Streicher-USA TODAY Sports) Nick Castellanos signed a five-year, $100 million contract with the Philadelphia Phillies before last ...
Padres seek season-high 8th straight win when they face Cardinals
(Photo credit: Kirby Lee-USA TODAY Sports) All season, Padres manager Bob Melvin has been looking for a winning streak longer ...
